Skip to content
Politically.com Search all
Menu

2026 · 2nd Quarter (Apr 1 - June 30)

NMDP

Filed by VAN SCOYOC ASSOCIATES.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-09-14 06:26:07 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 17, 2026
Income
$110,000.00
Expenses
Not reported
Client
NMDP
Filing UUID
b47f8025-185e-4655-8d8c-8d29c5bd50b5
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

H.R.5160, Stem Cell Therapeutic and Research Reauthorization Act of 2025, Cellular Transplant related issues and initiatives; and Reauthorization related issues S.4109, Stem Cell Therapeutic and Research Reauthorization Act of 2026, Entirety Transplant related issues, generally Monitor the following: Transplant courier issues FDA, Laboratory Developed Tests related issues Public Law 119-21, One Big Beautiful Bill Act, Health care coverage related issues

Literal federal measure citations: H.R.5160, S.4109

HOM · Homeland Security

Monitor Transplant courier issues

AVI · Aviation/Airlines/Airports

Monitor Transplant courier policy related issues

BUD · Budget/Appropriations

Donor recruitment and transplant services, as follows: H.R.9495, Department of Defense Appropriations Act, 2027 H.R.9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027

Literal federal measure citations: H.R.9495, H.R.9260

DEF · Defense

H.R.9495, Department of Defense Appropriations Act, 2027, Donor recruitment and transplant services

Literal federal measure citations: H.R.9495

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.